News
Ulcerated Primary Melanomas Respond to Adjuvant Interferon
Ulcerated Primary Melanomas Respond to Adjuvant Interferon
N Osterweil
20090515
2009 Jun 15
Elsevier Global Medical News
Ulcerated Primary Melanomas Respond to Adjuvant Interferon
Elsevier Global Medical News. 2009 Jun 15, N Osterweil
ORLANDO (EGMN) - Although ulcerated primary melanomas are notorious for having a poor prognosis, the presence of ulceration may be a signal that the tumor is one of a small proportion of melanomas that are sensitive to adjuvant interferon, European researchers suggested at the annual meeting of the American Society of Clinical Oncology.A meta-analysis of two large published studies of adjuvant interferon therapy indicates that interferon treatment of ulcerated primary melanoma is associated with...
Advisory and Editorial Boards
Meet OncologySTAT's Advisory and Editorial Boards that represent community practitioners and academic specialists with cross-disciplinary expertise.Editors' Choice
Neoadjuvant Trastuzumab improves event-free survival in HER2+ locally advanced or inflammatory breast cancer.